| Literature DB >> 35846016 |
Lei Shen1,2, Yanran Zhang3, Wenfeng Chen2, Xinghui Yin1.
Abstract
Background: Recurrent implantation failure (RIF) refers to that infertile patients have undergone multiple in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) cycles and transferred multiple embryos without embryo implantation or clinical pregnancy. Due to the lack of clear evidence-based medical guidelines for the number of embryos to be transferred in RIF patients, how to obtain the highest single cycle pregnancy success rate with as few embryos transferred as possible while avoiding multiple pregnancy as much as possible, that is, how to balance the pregnancy success rate and multiple pregnancy rate, is a great challenge for clinicians and RIF patients. We urgently need an effective and reliable assisted decision-making method to help clinicians find this balance, and an artificial intelligence (AI) system will provide an efficient solution. Design andEntities:
Keywords: IVF; RIF; artificial Intelligence; embryo transfer; machine learning
Year: 2022 PMID: 35846016 PMCID: PMC9280084 DOI: 10.3389/fphys.2022.885661
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
FIGURE 1Data set construction flowchart.
Description of 45 fields in the data set.
| Field name | Field type | Description |
|---|---|---|
| Patient age at treatment | Categorical | Patient age at treatment, banded as follows: 18–34, 35–37, 38–39, 40–42, 43–44, 45–50 |
| Date patient started trying to become pregnant or date of last pregnancy | Numeric | The number of years ago that patient started trying to become pregnant or years since last pregnancy |
| Type of infertility—female primary | Categorical | 1 if the patient has never been pregnant, 0 otherwise |
| Type of infertility—female secondary | Categorical | 1 if the patient has ever been pregnant, 0 otherwise |
| Type of infertility—male primary | Categorical | 1 if the partner has never impregnated any woman, 0 otherwise |
| Type of infertility—male secondary | Categorical | 1 if the partner has ever impregnated some woman, 0 otherwise |
| Type of infertility—couple primary | Categorical | 1 if the patient has never been pregnant while the partner has never impregnated any woman, 0 otherwise |
| Type of infertility—couple secondary | Categorical | 1 if the patient has ever been pregnant while the partner has ever impregnated some woman, 0 otherwise |
| Cause of infertility—tubal disease | Categorical | 1 if the primary cause of infertility is due to tubal disease, 0 otherwise |
| Cause of infertility—ovulatory disorder | Categorical | 1 if the primary cause of infertility is due to ovulatory disorder, 0 otherwise |
| Cause of infertility—male factor | Categorical | 1 if the primary cause of infertility is due to the partner, 0 otherwise |
| Cause of infertility—patient unexplained | Categorical | 1 if the primary cause of infertility is unknown, 0 otherwise |
| Cause of infertility—endometriosis | Categorical | 1 if the primary cause of infertility is due to endometriosis, 0 otherwise |
| Cause of infertility—cervical factors | Categorical | 1 if the primary cause of infertility is due to cervical factors, 0 otherwise |
| Cause of infertility—partner sperm concentration | Categorical | 1 if the primary cause of infertility is due to partner sperm concentration, 0 otherwise |
| Cause of infertility—partner sperm morphology | Categorical | 1 if the primary cause of infertility is due to partner sperm morphology, 0 otherwise |
| Cause of infertility—partner sperm motility | Categorical | 1 if the primary cause of infertility is due to partner sperm motility, 0 otherwise |
| Cause of infertility—partner sperm immunological factors | Categorical | 1 if the primary cause of infertility is due to partner sperm immunological factors, 0 otherwise |
| Stimulation used | Categorical | 1 if this was a stimulated cycle, 0 otherwise |
| Specific treatment type | Categorical | The specific treatment type used in this cycle, includes IVF, ICSI. |
| PGD | Categorical | 1 if this cycle involved the use of preimplantation genetic diagnosis, 0 otherwise |
| PGD treatment | Categorical | 1 if this cycle would be contained in the “PGD” CaFC category on the HFEA website, 0 otherwise |
| PGS | Categorical | 1 if this cycle involved the use of preimplantation genetic screening, 0 otherwise |
| PGS treatment | Categorical | 1 if this cycle would be contained in the “PGS” CaFC category on the HFEA website, 0 otherwise |
| Elective single embryo transfer | Categorical | 1 if this cycle involved the deliberate use of only one embryo, 0 otherwise |
| Fresh cycle | Categorical | 1 if this cycle used fresh embryos, 0 otherwise |
| Frozen cycle | Categorical | 1 if this cycle used frozen embryos, 0 otherwise |
| Eggs thawed | Numeric | If this cycle used frozen eggs, the number of eggs thawed |
| Fresh eggs collected | Numeric | The number of eggs collected in this cycle |
| Fresh eggs stored | Numeric | The number of eggs collected in this cycle and subsequently frozen |
| Total eggs mixed | Numeric | The number of eggs mixed with sperm |
| Eggs mixed with partner sperm | Numeric | The number of eggs mixed with sperm from the partner |
| Total embryos created | Numeric | The total number of embryos created in this cycle |
| Eggs micro-injected | Numeric | The number of eggs that were injected with sperm e.g., By ICSI. |
| Embryos from eggs micro-injected | Numeric | The number of embryos that were created in this cycle using ICSI. |
| Total embryos thawed | Numeric | If this was a frozen cycle, the total number of embryos that were thawed |
| Embryos transferred from eggs micro-injected | Numeric | The number of embryos transferred into the patient in this cycle that were created using ICSI. |
| Embryos stored for use by patient | Numeric | The number of embryos that were created in this cycle and then frozen for subsequent use by the patient |
| Embryos (from eggs micro-injected) stored for use by patient | Numeric | The number of embryos that were created in this cycle by injecting sperm and then frozen for subsequent use by the patient |
| Date of egg collection | Numeric | The number of days between egg collection and the first date provided in the series: egg collection date; egg thaw date; egg mix date; embryo thaw date; embryo transfer date |
| Date of egg thawing | Numeric | The number of days between egg thawing and the first date provided in the series: egg collection date; egg thaw date; egg mix date; embryo thaw date; embryo transfer date |
| Date of egg mixing | Numeric | The number of days between egg mixing and the first date provided in the series: egg collection date; egg thaw date; egg mix date; embryo thaw date; embryo transfer date |
| Date of embryo thawing | Numeric | The number of days between embryo thawing and the first date provided in the series: egg collection date; egg thaw date; egg mix date; embryo thaw date; embryo transfer date |
| Date of embryo transfer | Numeric | The number of days between embryo transfer and the first date provided in the series: egg collection date; egg thaw date; egg mix date; embryo thaw date; embryo transfer date |
| Early outcome | Categorical | 1 if there was an intrauterine fetal pulsation seen due to this cycle, 0 otherwise |
Evaluation metrics of all models.
| Model | Accuracy (%) | Precision (%) | Recall (%) | Sensitivity (%) | Specificity (%) | F1-score (%) | AUC-ROC | AUC-PR |
|---|---|---|---|---|---|---|---|---|
| Group A ( | ||||||||
| RF | 73.16 | 74.87 | 68.67 | 68.67 | 77.54 | 71.64 | 0.7856 | 0.7902 |
| GBDT | 76.02 | 77.85 | 71.85 | 71.85 | 80.08 | 74.73 | 0.8066 | 0.8134 |
| AdaBoost | 76.16 | 78.23 | 71.64 | 71.64 | 80.57 | 74.79 | 0.8129 | 0.8206 |
| MLP | 76.25 | 79.58 | 69.79 | 69.79 | 82.55 | 74.36 | 0.8139 | 0.8197 |
| Group B ( | ||||||||
| RF | 84.71 | 86.31 | 83.10 | 83.10 | 86.36 | 84.67 | 0.8954 | 0.9003 |
| GBDT | 85.06 | 85.60 | 84.89 | 84.89 | 85.23 | 85.24 | 0.9025 | 0.9043 |
| AdaBoost | 84.50 | 85.24 | 84.07 | 84.07 | 85.09 | 84.94 | 0.9031 | 0.9114 |
| MLP | 84.22 | 87.02 | 81.04 | 81.04 | 87.50 | 83.93 | 0.8969 | 0.9032 |
FIGURE 2The ROC curves and P-R curves of the four models in Group A. (A–D) The ROC curves and AUC scores of four models in Group A: the dark blue curve refers to the ROC curve, the area under the curve is covered by light blue color and the AUC score is clearly marked. (E–H) The P-R curves and AUC scores of four models in Group A: the dark blue curve refers to the P-R curve, the area under the curve is covered by light blue color and the AUC score is clearly marked.
FIGURE 4Comprehensive comparison of four models. (A) Comprehensive ROC curves of four models in Group A: the larger the area under the curve, the better the performance. (B) Comprehensive P-R curves of four models in Group A: the larger the area under the curve, the better the performance. (C) Comprehensive ROC curves of four models in Group B. (D) Comprehensive P-R curves of four models in Group B.
FIGURE 3The ROC curves and P-R curves of the four models in Group B. (A–D) The ROC curves and AUC scores of four models in Group B: the dark orange curve refers to the ROC curve, the area under the curve is covered by light orange color and the AUC score is clearly marked. (E–H) The P-R curves and AUC scores of four models in Group A: the dark orange curve refers to the P-R curve, the area under the curve is covered by light orange color and the AUC score is clearly marked.